3D-LLDM: Label-Guided 3D Latent Diffusion Model for Improving High-Resolution Synthetic MR Imaging in Hepatic Structure Segmentation

arXiv cs.CV / 3/26/2026

📰 NewsSignals & Early TrendsIdeas & Deep AnalysisModels & Research

Key Points

  • The paper introduces 3D-LLDM, a label-guided 3D latent diffusion model designed to generate high-resolution synthetic hepatic MRI volumes together with corresponding anatomical segmentation masks.
  • It leverages hepatobiliary phase MR images enhanced with the Gd-EOB-DTPA contrast agent to derive masks for the liver, portal vein, hepatic vein, and hepatocellular carcinoma, which then guide diffusion-based volumetric synthesis via a ControlNet-style architecture.
  • Trained on 720 real clinical scans from Samsung Medical Center, 3D-LLDM reports improved generative quality, achieving an FID of 28.31 that surpasses GANs by 70.9% and diffusion baselines by 26.7%.
  • The authors show practical downstream value: using the synthetic volumes for augmentation improves hepatocellular carcinoma segmentation by up to +11.153 Dice score across five different CNN architectures.

Abstract

Deep learning and generative models are advancing rapidly, with synthetic data increasingly being integrated into training pipelines for downstream analysis tasks. However, in medical imaging, their adoption remains constrained by the scarcity of reliable annotated datasets. To address this limitation, we propose 3D-LLDM, a label-guided 3D latent diffusion model that generates high-quality synthetic magnetic resonance (MR) volumes with corresponding anatomical segmentation masks. Our approach uses hepatobiliary phase MR images enhanced with the Gd-EOB-DTPA contrast agent to derive structural masks for the liver, portal vein, hepatic vein, and hepatocellular carcinoma, which then guide volumetric synthesis through a ControlNet-based architecture. Trained on 720 real clinical hepatobiliary phase MR scans from Samsung Medical Center, 3D-LLDM achieves a Fr\'echet Inception Distance (FID) of 28.31, improving over GANs by 70.9% and over state-of-the-art diffusion baselines by 26.7%. When used for data augmentation, the synthetic volumes improve hepatocellular carcinoma segmentation by up to 11.153% Dice score across five CNN architectures.